| Withdrawn | N/A | 0 | US | Lisdexamfetamine, Vyvanse, Estradiol, Estrogen, Placebo | University of Pennsylvania | Planned RRSO | 07/13 | 07/13 | | |
LDX, NCT01986777: for the Treatment of Cognitive Functioning Issues in Women Post-Oophorectomy |
|
|
| Withdrawn | N/A | 0 | US | lisdexamfetamine, Vyvanse, Placebo | University of Pennsylvania | Cognitive Impairments, RRSO | 12/13 | 12/13 | | |